纵横研报
Ticker Detail

688198.SHG

¥85.07+3.86% 佰仁医疗 Medical Devices
00Reports China 医疗健康
Beijing Balance Medical Technology Co Ltd
医疗健康 · 医疗器械

Beijing Balance Medical Technology Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of artificial bioprosthetic valve medical devices in China and internationally. It offers bovine pericardial, porcine aortic tissue, and limiting expandable artificial biological heart valves, as well as tricuspid annuloplasty ring for heart valve repair and treatment. The company also provides outflow tract single valve patch, pulmonary valved conduit, cardiothoracic biopatch, thoracic surgery biological patch, and dacron patch, as well as ventricular septal defect occluder, PDA occluder, ASD occluder, and cardiovascular occluder delivery system for congenital heart disease treatment. In addition, it offers neurosurgery microvascular pressure relief gasket, neurosurgical biopatch, and biological hernia patch for soft tissue repair. The company was founded in 2001 and is headquartered in Beijing, China.

MARKET 市值 11.23B CNY PE 55.5x 52W ¥75 – ¥132.94 EODHD · Q 2026-03-31 · 同步 2026-07-14
QUALITY PEG 营收 YoY 43.4% ROE 14.6% 营业利润率 33.8% 净利润率 30.5%
ANALYST 股息率 0.93%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制